Publications Office of the EU
How science supported EU policy making in ensuring safe and reliable COVID-19 antigen testing
DisplayCustomHeader
MyPortal
Deutsch
BasketSummary
Webcontentanzeige
Publication Detail Actions Portlet

Hilfsprogramme

Publication Detail Actions Portlet
 Benutzerbewertung
custom-survey-notification
Publication Detail Portlet

Publication detail

Home

How science supported EU policy making in ensuring safe and reliable COVID-19 antigen testing

Lessons learnt and recommendations in case of future serious crossborder health threats

Metadaten zur Veröffentlichung

In response to the challenges posed by the COVID-19 pandemic and the needs of EU Member States and policy makers related to antigen testing, DG SANTE and the JRC set up a structured targeted approach, which also facilitated the implementation of the EU Digital COVID Certificate (EUDCC). The EU Health Security Committee established in May 2021 a technical working group (TWG) on COVID-19 diagnostic tests. The TWG, consisting of technical experts from 27 EU Member States and Norway, as well as DG SANTE, JRC and ECDC, reviewed proposals put forward by manufacturers for devices to be included in the EU common list of COVID-19 antigen tests. The COVID-19 In Vitro Diagnostic Devices and Test Methods Database, a broadly publicly accessible repository of information on the performance of testing devices and methods for the detection of COVID-19, was created and used by the manufacturers to provide the TWG with the data necessary for their assessment of the proposals against a set of agreed criteria. Devices meeting the criteria were included in the EU common list of COVID-19 antigen tests, upon agreement by the EU Health Security Committee. An automated extraction of data from the JRC database was the basis for the retrieval of information used for the issuing of EUDCC certificates based on COVID-19 antigen testing. This report presents the scientific process put in place to support policy making in the EU’s response to the COVID-19 pandemic as regards antigen testing. It highlights critical steps, lessons learnt and concrete recommendations, which may be crucial for the implementation of similar systems in the unfortunate event of a future outbreak of a serious cross-border health threat.
Mehr anzeigen
Weniger anzeigen
ISSN 1831-9424
ISBN 978-92-68-18337-3
DOI 10.2760/787170
Katalognummer KJ-NA-31-980-EN-N
ISSN 1018-5593
ISBN 978-92-68-18336-6
DOI 10.2760/573813
Katalognummer KJ-NA-31-980-EN-C
PDF
ISSN 1831-9424 ISBN 978-92-68-18337-3 DOI 10.2760/787170 Katalognummer KJ-NA-31-980-EN-N
Gedruckt
ISSN 1018-5593 ISBN 978-92-68-18336-6 DOI 10.2760/573813 Katalognummer KJ-NA-31-980-EN-C
  • Released on EU publications website:
Diese Veröffentlichung kann im weboptimierten (PDF) oder druckoptimierten Format (PDF/X) heruntergeladen werden. Weitere Informationen zum Druck Ihrer eigenen Kopie von EU-Veröffentlichungen finden Sie in unserem Abschnitt „Häufig gestellte Fragen“.
Publication Viewer

Dokumentanzeige

Pop up window annotations